Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
1 dead as Typhoon Kalmaegi dumps heavy rains over central Philippines
Saudi Crown Prince bin Salman to visit Trump in White House
Man charged with 10 counts of attempted murder after knife attack on UK train
Tanzania's Hassan sworn into office after deadly election violence
Powerful 6.3 quake kills at least 20 in Afghanistan, hundreds injured
Turkey set to call for action on Gaza as soon as possible, source says
Hamas hands over three more hostage bodies
India federal agency freezes Anil Ambani Group's $853 million properties
